Psychemedics Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 5.86 million compared to USD 6.51 million a year ago. Net loss was USD 0.384 million compared to net income of USD 0.039 million a year ago.

Diluted loss per share from continuing operations was USD 0.07 compared to diluted earnings per share from continuing operations of USD 0.01 a year ago.